{"id":475557,"date":"2020-03-23T12:38:01","date_gmt":"2020-03-23T12:38:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=475557"},"modified":"2020-03-23T12:38:01","modified_gmt":"2020-03-23T12:38:01","slug":"alopecia-areata-market-size-and-share-market-research-reports-and-forecast-till-2030-delveinsight","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/alopecia-areata-market-size-and-share-market-research-reports-and-forecast-till-2030-delveinsight_475557.html","title":{"rendered":"Alopecia Areata Market Size and share, Market research reports and Forecast till 2030 | DelveInsight"},"content":{"rendered":"
\"Alopecia<\/a><\/div>\n
DelveInsight’s “Alopecia Areata – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Alopecia Areata, historical and forecasted epidemiology as well as the Alopecia Areata market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/p>\n<\/div>\n

Albany, NY –<\/strong> DelveInsight launched its new report on Alopecia Areata – Market Insights, Epidemiology, and Market Forecast-2030<\/a><\/p>\n

DelveInsight’s “Alopecia Areata – Market Insights, Epidemiology, and Market Forecast-2030<\/strong>” report delivers an in-depth understanding of the Alopecia Areata, historical and forecasted epidemiology as well as the Alopecia Areata market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/p>\n

The key fact of the report:<\/strong>
“Alopecia Areata affects approximately two per cent of the general population at some point during their lifetime.”<\/strong><\/p>\n

Key benefits of the report:
<\/strong>1. Alopecia Areata market report covers a descriptive overview and comprehensive insight of the Alopecia Areata epidemiology and Alopecia Areata market in the 7 MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
2. Alopecia Areata market report provides insights on the current and emerging therapies.
3. Alopecia Areata market report provides a global historical and forecasted market covering drug outreach in 7 MM.
4. Alopecia Areata market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Alopecia Areata market.<\/p>\n

Download a free sample report<\/strong>: https:\/\/www.delveinsight.com\/sample-request\/alopecia-areata-market<\/p>\n

“Alopecia Areata patients experience their first onset by age 40 years in 82.6–88% of patients and by age 20 years in 40.2% of patients.”<\/strong><\/p>\n

\"\"<\/strong><\/p>\n

Key pharma players involved in Alopecia Areata market:<\/strong>
1. Pfizer
2. LEO Pharma
3. Legacy Healthcare SA
4. Aclaris Therapeutics
5. Concert Pharmaceuticals
6. Energenesis Biomedical<\/p>\n

The launch of emerging therapies that will significantly impact the Alopecia Areata market during the study period (2019–2030) are:-
<\/strong>1. PF-06651600 and PF-06700841
2. LH-8
3. ATI-502
4. CTP-543
5. ENERGI-F701<\/p>\n

Table of contents:<\/strong><\/p>\n

1. Report Introduction<\/span>
2. Alopecia Areata Market Overview at a Glance<\/span>
3. Alopecia Areata Disease Background and Overview<\/span>
4. Alopecia Areata Epidemiology and Patient Population<\/span>
5. Alopecia Areata Country- Wise Epidemiology<\/span>
5.1. United States<\/span>
5.2. EU-5<\/span>
5.2.1. Assumptions and Rationale<\/span>
5.2.2. Germany<\/span>
5.2.3. France<\/span>
5.2.4. Italy<\/span>
5.2.5. Spain<\/span>
5.2.6. United Kingdom<\/span>
5.3. Japan<\/span>
6. Alopecia Areata Treatments & Medical Practices<\/span>
7. Alopecia Areata Emerging Therapies<\/span>
7.1. Key Cross Competition<\/span>
7.2. LH-8\/ Charite: Legacy Healthcare SA<\/span>
7.3. PF – 06651600: Pfizer<\/span>
7.4. ATI50002: Aclaris Therapeutics<\/span>
8. Alopecia Areata Market Size<\/span>
9. 7MM Alopecia Areata Country-Wise Market Analysis<\/span>
9.1. United States Market Size<\/span>
9.2. Germany Market Size<\/span>
9.3. France Market Size<\/span>
9.4. United Kingdom Market Size<\/span>
9.5. Spain Market Size<\/span>
9.6. Italy Market Size<\/span>
9.7. Japan Market Size<\/span>
10. Alopecia Areata Report Methodology<\/span>
11. DelveInsight Capabilities<\/span>
12. Disclaimer<\/span>
13. About DelveInsight<\/span><\/p>\n

Click here and download a full report on Alopecia Areata market.<\/a><\/p>\n

Related reports:<\/strong><\/p>\n

Alopecia Pipeline Insight, 2020<\/a><\/p>\n

Alopecia – Epidemiology Forecast to 2030<\/a> <\/p>\n

Media Contact<\/span>
Company Name:<\/strong> DelveInsight Business Research LLP<\/a>
Contact Person:<\/strong> Kritika Rehani
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> 9193216187
Address:<\/strong>304 S. Jones Blvd #2432
City:<\/strong> Las Vegas
State:<\/strong> Nevada
Country:<\/strong> United States
Website:<\/strong> https:\/\/www.delveinsight.com\/<\/a><\/p>\n

<\/object>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

DelveInsight’s “Alopecia Areata – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Alopecia Areata, historical and forecasted epidemiology as well as the Alopecia Areata market trends in the United States, EU5 (Germany, Spain, Italy, France, … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,435,405,406,404],"tags":[],"class_list":["post-475557","post","type-post","status-publish","format-standard","hentry","category-Business","category-Europe","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/475557","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=475557"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/475557\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=475557"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=475557"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=475557"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}